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Peptide hormone action on renal phosphate handling
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The phosphorus in plasma is present almost entirely as inor-
ganic phosphate (Pi) and renal handling of Pi plays a major role
in regulating the plasma level of Pi. About 95% of plasma Pi is
ultrafilterable at the glomerulus and, under normal conditions,
about 20% of the filtered Pi is excreted in the urine. Secretion of
Pi does not appear to be an important transport process in the
mammalian kidney. The convoluted and straight segments of the
proximal tubule are the major nephron sites where filtered Pi is
reabsorbed. Reabsorption in the proximal tubule is a saturable
process, and the Tm is influenced by the prevailing metabolic and
hormonal conditions [1]. The peptide hormones that influence
renal Pi handling exert their effects primarily by changing Pi
reabsorption in the proximal tubule. The initial, probably rate-
limiting, step in Pi reabsorption is entry into the proximal tubule
cell through the action of a Na/Pi cotransport system in the apical
brush border membrane (BBM). The efflux (and influx) step
across the basolateral membrane is less well-defined and more
than one transport mechanism may be involved. The evidence for
these steps in transcellular transport has been reviewed recently
[2, 3]. Regulation of tubular reabsorption of Pi by many different
factors appears to be accomplished, at least in part, through
changes in the Na/Pi cotransport capacity of the apical BBM. This
review is focused on the regulation of this step by peptide
hormones and growth factors (Table 1).
Stimulation of Na/Pi cotransport
Insulin
There are insulin receptors in the basolateral membrane of the
proximal tubule [4]. A direct stimulatory effect of insulin on the
renal Na/Pi cotransporter was demonstrated in vitro by incubation
of proximal tubule segments from canine kidney with physiolog-
ical concentrations of insulin, followed by preparation of BBM
vesicles for direct assessment of Na/Pi cotransport [5]. These
findings were complemented by studies in vivo that used soma-
tostatin infusion to depress plasma insulin levels in rats. Soma-
tostatin increased Pi delivery to the late proximal tubule and
increased Pi excretion [6]. This was independent of parathyroid
hormone (PTH) and other consequences of somatostatin action,
and suggested a role for endogenous insulin in regulating Na/Pi
cotransport. There is evidence that insulin also might be involved
in the up-regulation of renal Na/Pi cotransport in response to
acute Pi deprivation. This was suggested by the discovery of a
transient increase in plasma insulin after rats were given a low Pi
meal [7]. Further in vivo studies showed that the established
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up-regulatory response of the rat renal Na/Pi cotransporter to Pi
deprivation was not maintained during subsequent induction of a
diabetic state [8]. A complementary approach [9] showed that the
renal Na/Pi cotransporter in diabetic rats was not up-regulated by
subsequent Pi deprivation, but the adaptation was restored by
exogenous insulin. Preliminary data from Western blots (Kemp-
son, Murer and Biber, unpublished observations) indicate that the
increased abundance of Na/Pi cotransporter protein in the BBM
of Pi deprived rats [10] did not occur in the Pi-deprived diabetic
rats but was restored by insulin treatment. Thus the Na/Pi
cotransport activity correlated with the abundance of Na/Pi
cotransporter protein in the BBM. Although insulin has a direct
action on the Na/Pi cotransporter in an in vitro setting, both in
proximal tubules and cultured OK cells [5, 11, 12], it remains to be
determined if the apparent insulin-dependence of the up-regula-
tion of Na/Pi cotransport during Pi deprivation is due to a renal
action of insulin or if it is an indirect effect of other actions of
insulin, such as prevention of the hyperglycemia present in
diabetic rats. It is interesting to note that both the direct stimu-
latoiy effect of insulin on Na/Pi cotransport in OK cells and the
acute adaptive increase in renal Na/Pi cotransport during Pi
deprivation, do not require de novo protein synthesis [11, 13].
Growth hormone and insulin-like growth factor (IGF)-1
Chronic administration of growth hormone to dogs increased
tubular Pi reabsorption independently of PTH [14], an effect
shown subsequently to be accompanied by specific stimulation of
the Na/Pi cotranporter in the BBM [15]. Suppression of growth
hormone secretion in immature rats decreased the tubular capac-
ity for Pi reabsorption [16]. There are receptors for growth
hormone in the renal proximal tubule that lead to activation of
phospholipase C [17], but Pi transport is not regulated acutely by
growth hormone [18]. The chronic action of growth hormone is
probably mediated by IGF-1. Renal production of IGF-1 is
stimulated by growth hormone and IGF-1 receptors are present in
the basolateral membrane of proximal tubule cells [19]. Chronic
administration of IGF-1 to hypophysectomized rats stimulated the
tubular capacity for Pi reabsorption and the effect did not involve
PTH. This action of IGF-1 was accompanied by specific stimula-
tion of the Na/Pi cotransporter in the BBM [20], similar to growth
hormone action in dogs [14]. Direct addition of IGF-1 to mi-
croperfused rabbit proximal tubules produced specific stimulation
of phosphate transport [18] and incubation of OK cells with IGF-1
also stimulated Na/Pi cotransport [21]. The stimulatory effect in
OK cells produced an increase in the Vm and required de novo
protein synthesis. The IGF-1 concentrations were much lower
than those required for stimulation by insulin, suggesting that
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Growth hormone Atrial natriuretic peptide
Insulin-like growth factor 1 Epidermal growth factor
Transforming growth factors a and 13
Parathyroid hormone-related protein
Parathyroid hormone
IGF-1 action was not mediated by insulin receptors (21]. Further
studies in OK cells suggested a role for tyrosine phosphoiylation
in mediating changes in Na/Pi cotransport. Vanadate increased
tyrosine kinase activity and stimulated Na/Pi cotransport, while in
contrast, genistein decreased tyrosine kinase and inhibited Na/Pi
cotransport. These effects were dose-dependent and there was a
close correlation between the activities of tyrosine kinase and Pi
transport [221. Since the receptor for IGF-1 activates an intrinsic
tyrosine kinase, the possibility exists that IGF-1 modulates Pi
transport at the cellular level by an intracellular pathway that
involves protein tyrosine phosphorylation. It is not known if the
end result of this pathway is to increase the abundance of Na/Pi
cotransporters in the renal BBM.
Inhibition of Na/Pi cotransport
Calcitonin
Pharmacological doses of calcitonin increase Pi excretion in rats
but this effect could be due, in part, through release of PTH in
response to the hypocalcemia. A direct effect to decrease the
tubular capacity for Pi reabsorption was demonstrated in thyro-
parathyroidectomized (TPTX) rats [23] and the proximal tubule is
the primary site of action [24]. Inhibition of Pi transport in the rat
proximal tubule is probably mediated by specific inhibition of the
Na/Pi cotransporter in the apical BBM [25]. Since calcitonin does
not stimulate adenylate cyclase in microdissected proximal tu-
bules [2], the inhibition of Na/Pi cotransport is unlikely mediated
by cyclic AMP. The role of calcitonin in Pi homeostasis is unclear
because changes in endogenous secretion of calcitonin do not
produce consistent changes in Pi metabolism. The principle action
of calcitonin may be on bone and its primary physiological role in
the kidney may be to conserve calcium and magnesium.
A trial natriuretic peptide
In the absence of endogenous PTH, infusion of atrial natri-
uretic peptide (ANP) increases Pi excretion in both rats and dogs
[1, 2]. In BBM vesicles from the ANP-treated rats there was
decreased Na/Pi cotransport and decreased Na/H exchange but
no change in other Na-dependent transporters [26, 271. A similar
trend was observed in OK cells following incubation with ANP
and both effects were reproduced by 8-bromo-cyclic GMP, sug-
gesting that cyclic GMP may be an intracellular mediator [21. The
response of Na/cotransport systems to ANP infusion in vivo may
he mediated indirectly through stimulation of intrarenal dopa-
mine production in response to ANP [28].
Epidermal growth factor
The mouse kidney is a major site of synthesis of the epidermal
growth factor (EGF) precursor [29] and several segments of the
rabbit nephron, including the convoluted and straight segments of
the proximal tubule, have EGF receptors [30]. EGF has direct
effects on several renal cell functions [311 including stimulation of
Pi transport in perfused proximal tubules from rabbit kidney [32].
This effect was reproduced in cultured renal epithelial LLC-PK1
cells [33] but not in OK cells where EGF (10 ng/ml) inhibited
Na/Pi cotransport [31, 34]. The response to EGF in both cell lines
required incubations of 18 to 24 hours. The inhibitory response in
OK cells involved a decreased Vmax, was blocked by inhibitors of
RNA and protein synthesis and phospholipase C activity, and was
accompanied by a two- to threefold decrease in abundance of the
Na/Pi cotransporter specific mRNA [31]. EGF may induce syn-
thesis of a regulatory protein that inhibits the synthesis and/or
intracellular processing of the Na/Pi cotransporter. EGF action
was not dependent on cyclic AMP or prostaglandin E2 [34] but
may be due to activation of the catalytic activity of phospholipase
C-yl by the tyrosine kinase activity of the EGF receptor [35].
Increased activity of phospholipase C-yl leads ultimately to activa-
tion of protein kinase C. The opposing effects of EGF in LLC-PK1
and OK cells results from the fact that activation of protein kinase C
stimulates Na/Pi cotransport in the former and inhibits it in the latter
cell line [31]. EGF stimulation of Pi transport in rabbit proximal
tubules was much more rapid (within 30 mm) compared to the
established cell lines and the stimulation was blocked by inhibitors of
tyrosine kinase and protein kinase C [36].
Transforming growth factors
During malignancy-associated hypercalcemia there may be
decreased tubular reabsorption of Pi and hypophosphatemia.
These changes may be due in part to tumor-produced circulating
factors that directly decrease renal Pi transport. One of these
factors is transforming growth factor (TGF)-a which produces an
increase in plasma calcium when injected into mice [37]. TGF-a
stimulates bone resorption and has been implicated in malignan-
cy-associated hypercalcemia [34]. Incubation of OK cells with
TGF-a (10 ng/ml) for 24 hours decreased Na/Pi cotransport by
35% [34]. The effects were time and dose-dependent and were
independent of cyclic AMP and prostaglandin E2 synthesis. These
responses are similar to the effects of EGF on OK cells (above)
and this may arise because the two polypeptides may share a
common receptor [38].
TGF-/3 is expressed in tumor cell lines and in normal tissues of
the mouse and is present in plasma in a protein-bound form [39].
It suppresses proliferation of cultured proximal tubule cells from
rabbit kidney and promotes type I collagen production by rat
kidney epithelial cells [39]. High affinity receptors for TGF-/3 are
present in glomerular and epithelial cells of mouse kidney [40].
Incubation of OK cells with TGF-p (3 ng/ml) produced specific
inhibition of Na/Pi cotransport within eight hours and the effect
was maximum at 18 hours when there was 50% inhibition of Pi
uptake [391. The inhibition was dependent on RNA and protein
synthesis but was independent of cyclic AMP, prostaglandin E2
synthesis, pertussis toxin-sensitive G proteins and protein kinase
C. It has been speculated that circulating TGF-p, like TGF-a,
might contribute to the hyphophosphatemia in malignancy-asso-
ciated hypercalcemia, but this is unclear at present.
Parathyroid hormone-related protein (PTHrP)
PTHrP is the major mediator of the hypercalcemia, phospha-
tuna and hypophosphatemia of malignancy-associated hypercal-
cemia [41]. At the amino terminus there is marked homology
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between PTH and PTHrP so that they bind with equal affinity to
identical receptors in the kidney. Thus PTHrP in vivo, in the
absence of PTH, increases renal tubular reabsorption of calcium,
decreases Pi reabsorption, and increases nephrogeneous cyclic
AMP [2, 41]. Direct addition of the ito 34 fragment of PTHrP to
OK cells stimulated cyclic AIvIP production and specifically
inhibited Na/Pi cotransport with a time- and dose-dependency
identical to PTH [42]. Pretreatment of OK cells with TGF-a
blunted the rise in cyclic AMP due to either PTH or PTHrP.
Furthermore, the inhibition of Na/Pi cotransport by TGF-x or
EGF was not increased further by subsequent addition of P11-I or
PTHrP [34]. It is possible that EGF produced in the kidney or
TGF-a from a renal tumor might modulate, via EGF receptors,
the response of renal cells to PTH or PTHrP. However, the
physiological significance of these interactions observed in cul-
tured cells remains to be determined. It has been suggested [34,
39] that TGF-a and TGF-13 may mediate the phosphaturia
observed in cases of malignant hypercalcemia where there is no
accompanying increase in urinary cyclic AMP.
Parathyroid hormone
The phosphaturic action of parathyroid hormone (PTH) has
been studied extensively and is due primarily to inhibition of Pi
reabsorption in the proximal tubule [1—3]. The straight segment
may be important for final regulation of Pi excretion by PTH,
especially in the rabbit [1]. PTH-induced inhibition of the Na/Pi
cotransporter in the apical BBM involves a decreased Vmax [15]
and probably accounts for the decrease in tubular Pi reabsorption.
PTH binds to specific receptors on the basolateral membrane [2]
and activates both the adenylate cyclase/protein kinase A system
and the phopholipase C/protein kinase C system. The rise in
intracellular calcium associated with the latter does not appear to
be directly involved in regulating Na/Pi cotransport. However,
there is considerable evidence that both protein kinase A- and
protein kinase C-dependent phosphorylation are important for
PTH-induced inhibition of Na/Pi cotransport. It is not yet known
if different subpopulations of PTH receptors are coupled to the
two intracellular pathways or if the Na/Pi cotransporter is phos-
phorylated when the pathways are activated by PTH binding. This
work has been reviewed in detail recently [2, 3] and will not be
discussed here.
Collaborative efforts between several laboratories have focused
on determining if the net result of PTH action, regardless of the
signal pathway, is a decrease in the abundance of the Na/Pi
cotransporter in the BBM. The progress of this work was greatly
facilitated by the availability of new tools as a result of the recent
cloning of the rat renal Na/Pi cotransporter (NaPi-2) [43]. The
possibility that PTH might promote endocytic removal of NaPi-2
was raised by the observation that colchicine, a microtubule
poison, blocked the phosphaturic action of PTH in rats [44]. More
direct evidence that PTH action on Na/Pi cotransport may be
mediated in part by endocytosis was obtained in OK cells. PTH
action on Na/Pi cotransport was significantly impaired when
endocytosis was inhibited [45]. Subsequent data from PTH-
treated rats provided further support for this idea. The Na-
dependent Pi-protectable binding of phosphonoformic acid, a
specific inhibitor of Na,Pi cotransport, was decreased in BBMV
from PTH-treated rats compared to controls. This was due to a
decrease in the binding capacity rather than the affinity [46] and is
consistent with the Vma,, change in Na/Pi cotransport [15]. Addi-
tional work in OK cells has shown that the onset of PTH action on
Na/Pi cotransport does not require de novo protein synthesis but
the recovery step, after PTH removal, is protein synthesis-depen-
dent [47]. This leads to the conclusion that the Na/Pi cotrans-
porter, once internalized, is probably degraded and not recycled
by exocytosis to the plasma membrane. Recovery from PTH
action will require synthesis of new transporters and trafficking to
the plasma membrane. Incubation of OK cells with PTH, under
conditions that inhibited plasma membrane Na/Pi cotransport
(Vmax effect), did not change total endocytic activity [48]. It was
proposed that PTH must stimulate selective removal of Na/Pi
cotransporters without changing the overall rate of constitutive
endocytosis. One possible role of the protein phosphorylation
pathways may be to phosphorylate the Na/Pi cotransporter so that
the attached Pi serves to label and/or inactivate it for shuttling
into areas where endocytic vesicles are being formed. Several
potential phosphorylation sites are present in the cytoplasmic
domains of the deduced amino acid sequence of NaPi-2 [43].
A polyclonal antibody to NaPi-2 proved to be invaluable for
further studies. Preliminary work with flow cytometry has de-
tected specific binding of the antibody to a non-denatured fraction
of light endosomes [49] that represents true intracellular endoso-
mal vesicles [50]. There was no specific binding to non-denatured
BBM, presumably because antigenic sites are on the inside surface
of BBM vesicles and are only exposed by denaturation. Thus the
binding to light endosomes indicates the presence of a true
intracellular pool of NaPi-2 that cannot be attributed to BBM
contamination of the endosomal preparation. Use of the antibody
for Western blots of denatured BBM has shown unequivocally
that the NaPi-2 abundance in BBM of parathyroidectomized
(PTX) rats was decreased by a one to two hour treatment with
PTH at a dose that inhibited Na/Pi cotransport [51 and LOtscher
et al, this issue]. The loss of NaPi-2 from the BBM was observed
in proximal tubules throughout the cortex, both superficial and
juxtamedullaiy, but there was no change in immunofluorescence
specific for y-glutamyltranspeptidase, a BBM marker enzyme.
Only a limited amount of intracellular NaPi-2 was detected by the
immunohistochemical technique, lending support to the notion
that internalized NaPi-2 may be rapidly degraded. Taken to-
gether, these findings strongly suggest that one mechanism by
which PTH inhibits renal Na/Pi cotransport at the cellular level
involves endocytic removal of Na/Pi cotransporters from the BBM
of the renal proximal tubule.
Conclusions
Plasma Pi is maintained within a narrow range, and since the
kidney plays a major role in Pi homeostasis it is perhaps not
surprising that many different factors regulate renal Pi transport.
Extrapolation of data from cultured OK cells to the intact animal
may not always be justified. The true physiological role of several
peptides that inhibit Na/Pi cotransport in OK cells remains to be
determined. None of the peptides discussed here has a primary
role as a regulator of renal Pi transport. A true Pi regulating
hormone has not been identified, although there has been a recent
report of heat-labile factor produced by tumor-induced osteoma-
lacia [52]. PTH remains the best characterized peptide hormone
in terms of the intracellular signals involved and the cellular
response. As work proceeds on understanding PTH action, the
findings may shed light on the mechanism of action of other
physiological regulators of renal Pi transport.
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